Intellia Therapeutics Inc buy Bank of America Co.
Start price
27.10.25
/
50%
€12.81
Target price
27.10.26
€25.78
Performance (%)
-13.11%
Price
24.03.26
€11.13
Summary
This prediction is currently active. The prediction for Intellia Therapeutics Inc disappoints with a performance of -13.11%. This prediction currently runs until 27.10.26. The prediction end date can be changed by Bank_of_America_Co_ at any time. Bank_of_America_Co_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Intellia Therapeutics Inc | -4.872% | -4.872% |
| iShares Core DAX® | -3.509% | -8.747% |
| iShares Nasdaq 100 | -2.782% | -0.632% |
| iShares Nikkei 225® | -2.038% | -6.841% |
| iShares S&P 500 | -2.598% | -2.230% |
Comments by Bank_of_America_Co_ for this prediction
In the thread Intellia Therapeutics Inc diskutieren
Intellia Therapeutics (NASDAQ:NTLA) had its price target lowered by analysts at Bank of America Corporation from $36.00 to $30.00. They now have a "buy" rating on the stock.
Ratings data for NTLA provided by MarketBeat